Costales-Carrera, A.; Fernández-Barral, A.; Bustamante-Madrid, P.; Guerra, L.; Cantero, R.; Barbáchano, A.; Muñoz, A.
Plocabulin Displays Strong Cytotoxic Activity in a Personalized Colon Cancer Patient-Derived 3D Organoid Assay. Mar. Drugs 2019, 17, 648.
https://doi.org/10.3390/md17110648
AMA Style
Costales-Carrera A, Fernández-Barral A, Bustamante-Madrid P, Guerra L, Cantero R, Barbáchano A, Muñoz A.
Plocabulin Displays Strong Cytotoxic Activity in a Personalized Colon Cancer Patient-Derived 3D Organoid Assay. Marine Drugs. 2019; 17(11):648.
https://doi.org/10.3390/md17110648
Chicago/Turabian Style
Costales-Carrera, Alba, Asunción Fernández-Barral, Pilar Bustamante-Madrid, Laura Guerra, Ramón Cantero, Antonio Barbáchano, and Alberto Muñoz.
2019. "Plocabulin Displays Strong Cytotoxic Activity in a Personalized Colon Cancer Patient-Derived 3D Organoid Assay" Marine Drugs 17, no. 11: 648.
https://doi.org/10.3390/md17110648
APA Style
Costales-Carrera, A., Fernández-Barral, A., Bustamante-Madrid, P., Guerra, L., Cantero, R., Barbáchano, A., & Muñoz, A.
(2019). Plocabulin Displays Strong Cytotoxic Activity in a Personalized Colon Cancer Patient-Derived 3D Organoid Assay. Marine Drugs, 17(11), 648.
https://doi.org/10.3390/md17110648